ÑÇÐÇÓÎÏ·¹ÙÍø-www.yaxin868.com

ɽ¶«ÑÇÐÇÓÎÏ·¹ÙÍø»ú´²ÓÐÏÞ¹«Ë¾Ï³´²¹Ù·½ÍøÕ¾½ñÌìÊÇ£º2025-06-06Çл»³ÇÊÐ[È«¹ú]-ÍøÕ¾µØÍ¼
ÍÆ¼ö²úÆ· :
ÍÆ¼öÐÂÎÅ
¼¼ÊõÎÄÕµ±Ç°Î»ÖÃ:¼¼ÊõÎÄÕÂ>

Ò»ÖÖ¼ì²âÊÜʵÑéÕßÌåÒºÌåÍâ´Ù½ø¼²²¡Ïà¹Øµ°°×Á×ËữÐÞÊÎÄÜÁ¦µÄ·½·¨

ʱ¼ä:2023-06-14    ×÷Õß: ¹ÜÀíÔ±

Ò»ÖÖ¼ì²âÊÜʵÑéÕßÌåÒºÌåÍâ´Ù½ø¼²²¡Ïà¹Øµ°°×Á×ËữÐÞÊÎÄÜÁ¦µÄ·½·¨
¡¾×¨ÀûÕªÒª¡¿±¾·¢Ã÷Éæ¼°Ò»ÖÖ¼ì²âÊÜÊÔÕßÌåÒºÌåÍâ´Ù½øÁ×ËữÐÞÊεļ²²¡Ïà¹Øµ°°×ÐγÉÄÜÁ¦µÄ·½·¨¡£¸ü¾ßÌåµØËµ£¬Éæ¼°Ò»ÖÖ¼ì²âÊÜÊÔÕßÌåÒºÌåÍâ´Ù½øÁ×ËữÐÞÊεļ²²¡Ïà¹Øµ°°×Èç¦Á-Í»´¥ºËµ°°×ÐγÉÄÜÁ¦µÄ·½·¨¡£¸Ã·½·¨°üÀ¨½«´¿»¯µÄÖØ×éÈ˼²²¡Ïà¹Øµ°°×ÓëÊÜÊÔÕßÌåÒºÔÚÒ»¶¨Î¶ÈϽøÐÐÕñµ´·õÓý£¬È»ºóÀûÓÃÄܹ»¼ì²âÁ×ËữÐÞÊε°°×Öʵķ½·¨¼ì²â·õÓýºóµÄÌåÒºÖÐÁ×ËữÐÞÊεļ²²¡Ïà¹Øµ°°×Èç¦Á-Í»´¥ºËµ°°×µÄº¬Á¿¡£
¡¾×¨Àû˵Ã÷¡¿Ò»ÖÖ¼ì²âÊÜʵÑéÕßÌåÒºÌåÍâ´Ù½ø¼²²¡Ïà¹Øµ°°×Á×ËữÐÞÊÎÄÜÁ¦µÄ·½·¨
¡¾¼¼ÊõÁìÓò¡¿:
[0001]±¾·¢Ã÷Éæ¼°Ò»ÖÖ¼ì²âÊÜÊÔÕßÌåÒºÌåÍâ´Ù½øÁ×ËữÐÞÊεļ²²¡Ïà¹Øµ°°×ÐγÉÄÜÁ¦µÄ·½·¨£¬¸Ã·½·¨¿ÉÓÃÓÚÅÁ½ðÉ­²¡µÄÕï¶Ï¡£
¡¾±³¾°¼¼Êõ¡¿:
[0002]ÅÁ½ðÉ­²¡ÊÇÒ»ÖÖ³£¼ûµÄÉñ¾­ÏµÍ³ÍËÐÐÐÔ¼²²¡£¬ÁÙ´²ÉÏÖ÷Òª±íÏÖΪ¾²Ö¹Õñ²ü¡¢Ô˶¯³Ù»º¡¢¼¡È⽩ֱºÍ×ËÊÆ²»Îȶ¨µÈÔ˶¯Ö¢×´(1£¬2)¡£ÒýÆðÕâЩ֢״µÄÔ­ÒòÊÇÖÐÄÔºÚÖʶà°Í°·Éñ¾­Ôª´óÁ¿ËÀÍöºÍÓÉ´ËÒýÆðµÄÎÆ×´Ì岿λµÄ¶à°Í°·Éñ¾­µÝÖʵĴó·ù¶È¼õÉÙ¡£ÅÁ½ðÉ­²¡µÄÖ÷Òª²¡ÀíÌØÕ÷ÊÇÉñ¾­Ï¸°ûÄÚ³öÏÖÊÈËáÐÔ°üº­Ìåһ·Ò×Ìå(Lewy body)ºÍ·Ò×Éñ¾­Ë÷(Lewyneurite)¡£¹¹³É·Ò×ÌåºÍ·Ò×Éñ¾­Ë÷µÄÖ÷Òª³É·ÖÊǦÁ-Í»´¥ºËµ°°×(a-synuclein) (3)¡£ÆäÖУ¬Ô¼90%µÄ¦Á-Í»´¥ºËµ°°×ΪÁ×ËữÐÞÊÎÐÎʽ(4)¡£´óÁ¿Ñо¿±íÃ÷£¬Á×ËữÐÞÊοɴٽø¦Á-Í»´¥ºËµ°°×µÄ¾ÛºÏ£¬´Ó¶øÔÚÅÁ½ðÉ­²¡µÄ·¢ÉúºÍ·¢Õ¹ÖÐÆð¹Ø¼üÐÔ×÷ÓÃ(5-9)¡£Òò´Ë£¬¼ì²âÁ×Ëữ¦Á-Í»´¥ºËµ°°×ÔÚÌåÒºÖеı仯±»ÈÏΪ¶ÔÅÁ½ðÉ­²¡¾ßÓÐÕï¶ÏÒâÒ塣ĿǰÑо¿±íÃ÷£¬ÅÁ½ðÉ­²¡ÈËѪҺÖÐÁ×Ëữ¦Á-Í»´¥ºËµ°°×º¬Á¿Ôö¸ß£¬¶ø×ܦÁ-Í»´¥ºËµ°°×¼°¹Ñ¾Û»¯¦Á-Í»´¥ºËµ°°×ÔòÎ޴˸ıä(7£¬10)¡£Òò´Ë£¬Á×Ëữ¦Á-Í»´¥ºËµ°°×¿ÉÄܳÉΪһÖÖÅÁ½ðÉ­²¡Õï¶ÏµÄDZÔÚ±ê¼ÇÎȻ¶ø£¬ÓÉÓÚ¼ì²â¼¼ÊõµÄÏÞÖÆ£¬ÑªÒºÖÐÁ×Ëữ¦Á-Í»´¥ºËµ°°×¼ì²âµÄÁéÃô¶È¼°ÌØÒì¶È½ÏµÍ¡£
[0003]ÏÖÓм¼ÊõÖжÔѪҺÖÐÁ×Ëữ¦Á -Í»´¥ºËµ°°×¼ì²â·½·¨Ö÷ÒªÓÐ:ÀûÓÃELISA·½·¨Ö±½Ó¼ì²âÆäº¬Á¿¡£
[0004]ÏÖÓз½·¨µÄȱÏÝÊÇ:»¼ÕߺͶÔÕյIJîÒì½ÏС£¬ºÜ¶àÊý¾ÝÖØµþ£¬ÄÑÒÔÓÃÓÚÁÙ´²¡£±¾·½·¨µÄÓÅÊÆ:Êý¾ÝÎȶ¨£¬»¼ÕߺͶÔÕÕ²îÒì½Ï´ó£»Ö÷Òª·´Ó³Ñª½¬´Ù½ø¦Á -Í»´¥ºËµ°°×Á×ËữµÄÄÜÁ¦¡£
[0005]Ϊ¿Ë·þÉÏÊöȱÏÝ£¬±¾·¢Ã÷ÌṩһÖÖ¼ì²âÊÜÊÔÕßÌåÒºÌåÍâ´Ù½øÁ×ËữÐÞÊεļ²²¡Ïà¹Øµ°°×Ðγɵķ½·¨£¬¸Ã·½·¨¾ßÓнϺõÄÎȶ¨ÐÔºÍÖØ¸´ÐÔ£¬¿ÉÒÔÏÔÖøÇø·ÖÅÁ½ðÉ­²¡È˺ÍÕý³£½¡¿µÈË£¬ÊÇÅÁ½ðÉ­²¡¸ßΣÈËȺɸѡ¡¢ÁÙ´²Õï¶Ï¼°²¡Çé¼à²âµÄÖØÒªÊֶΡ£

¡¾·¢Ã÷ÄÚÈÝ¡¿
:
[0006]±¾·¢Ã÷ÌṩһÖÖÅÁ½ðÉ­²¡µÄÕï¶Ï·½·¨£¬ÆäÖаüÀ¨¼ì²âÊÜÊÔÕßÌåÒºÌåÍâ´Ù½øÁ×ËữÐÞÊεļ²²¡Ïà¹Øµ°°×Èç¦Á-Í»´¥ºËµ°°×ÐγÉÄÜÁ¦µÄ·½·¨¡£
[0007]±¾·¢Ã÷½«´¿»¯µÄÖØ×éÈ˼²²¡Ïà¹Øµ°°×ÓëÊÜÊÔÕßÌåÒºÔÚÒ»¶¨Î¶ÈϽøÐÐÕñµ´·õÓý£¬È»ºóÀûÓÃÊó¿¹ÈËÁ×Ëữ-¦Á-Í»´¥ºËµ°°×µ¥¿Ë¡¿¹Ìå×÷Ϊ²¶»ñ¿¹Ì壬ÀûÓÃÉúÎïËØ»¯µÄÊó¿¹È˦Á -Í»´¥ºËµ°°×µ¥¿Ë¡¿¹Ìå×÷Ϊ¼ì²â¿¹Ì壬ÀûÓÿ¹Ô­-¿¹Ìå·´Ó¦Ô­Àí¼ì²âÅÁ½ðÉ­²¡È˺ÍÕý³£½¡¿µÈËÌåÒºÌåÍâ´Ù½ø¼²²¡Ïà¹Øµ°°×Á×ËữÐÞÊÎÐÎʽµÄÐγÉÄÜÁ¦²¢½øÐбȽÏ¡£
[0008]±¾·¢Ã÷¼ì²âÊÜÊÔÕßÌåÒºÌåÍâ´Ù½øÁ×ËữÐÞÊεļ²²¡Ïà¹Øµ°°×Èç¼ì²â¦Á -Í»´¥ºËµ°°×ÐγÉÄÜÁ¦µÄ·½·¨°üÀ¨ÒÔϲ½ÖèºÍÄÚÈÝ:[0009]I)·ÖÀëѪ½¬£»
[0010]2)¼ÓÈëÖØ×éÈ˦Á -Í»´¥ºËµ°°×£¬µÃµ½Á×Ëữ¦Á -Í»´¥ºËµ°°×£»
[0011]3)¿¹ÈËÁ×Ëữ-¦Á-Í»´¥ºËµ°°×µ¥¿Ë¡¿¹ÌåºÍÁ×Ëữ¦Á-Í»´¥ºËµ°°×ÒÔ¼°¿¹È˦Á -Í»´¥ºËµ°°×µ¥¿Ë¡¿¹Ìå·õÓý£¬Ëæºó¼ÓÈë¼îÐÔÁ×ËáøºÍÏÔÉ«¼Á£¬½øÐÐÏÔÉ«£»
[0012]4)Ó÷ֹâ¹â¶È·¨¶ÔÏÔÉ«µÄÑùÆ·½øÐÐÎü¹â¶È²â¶¨£¬¸ù¾Ý±ê×¼ÇúÏß¼ÆËãÑùÆ·ÖÐÁ×Ëữ¦Á-Í»´¥ºËµ°°×µÄº¬Á¿¡£
[0013]ÒÔ϶Ա¾·¢Ã÷ËùÓÃÃû³ÆÊõÓï½øÐнâÊÍ:
[0014]ÖØ×éÈ˦Á -Í»´¥ºËµ°°×:½«Ð¯´øÈ˦Á -Í»´¥ºËµ°°×»ùÒòµÄÖÊÁ£×ªÈ¾ÖÁ´ó³¦¸Ë¾ú£¬ÅàÑø¡¢ÌáÈ¡²¢´¿»¯»ñµÃµÄÅÁ½ðÉ­²¡Ïà¹Øµ°°×¡£
[0015]Á×Ëữ¦Á -Í»´¥ºËµ°°×:129λ˿°±Ëá·¢ÉúÁ×ËữÐÞÊεĦÁ -Í»´¥ºËµ°°×¡£
[0016]¿¹ÈËÁ×Ëữ-¦Á-Í»´¥ºËµ°°×µ¥¿Ë¡¿¹Ìå:¿¹Ô­Îªº¬129λÁ×ËữÐÞÊεÄË¿°±ËáÔÚÄÚµÄÈ˦Á-Í»´¥ºËµ°°×¶ÌëÄ£¬Æä°±»ùËáÐòÁÐΪGILEDMPVDTONEAYEMPSEEGYQDYEPEA£¬ÓëÁ鳤ÀදÎï·¢Éú·´Ó¦¡£±¾·¢Ã÷ʹÓõĿ¹ÈËÁ×Ëữ-¦Á-Í»´¥ºËµ°°×µ¥¿Ë¡¿¹ÌåÃû³ÆÎª:4¦¥6¿¹Ìå,ΪÒÑÖª¿¹Ìå,ÊÇSanta cruz¹«Ë¾ËùÊÛµÄp-a-synuclein (Ser129)¿¹Ìå(»õºÅ:sc-135638)¡£
[0017]¿¹È˦Á-Í»´¥ºËµ°°×µ¥¿Ë¡¿¹Ìå:3D5¿¹Ì壬ʶ±ð¦Á -Í»´¥ºËµ°°×µÚ115_121¸ö°±»ùËᣬ¿¹Ô­ÎªÈËÖØ×é¦Á-Í»´¥ºËµ°°×£¬ÓëÁ鳤ÀදÎï·¢Éú·´Ó¦¡£(¸Ã¿¹ÌåÒѾ­¹«¿ª£¬ÔÚ
S.Yu, et al.Neuroscience, 145 (2007) 539-555ÖÐÒѾ­·¢±í,¿Éͨ¹ý¹ºÂòµÃµ½)¡£Ò²¿ÉÒÔ°´ÕÕÒÔÏ·½·¨ÖƱ¸:
[0018]²½Öè1£¬µ°°×¿¹Ô­µÄÖÆ±¸:±¾ÊµÑéÊÒÖÆ±¸²¢´¿»¯ÈËÈ«³¤¦Á -Í»´¥ºËµ°°××÷Ϊ¿¹Ô­¡£
[0019]²½Öè2£¬ÃâÒßСÊó£»Ê¹Óø£ÊÏÍêÈ«×ô¼Á(µÚÒ»´ÎÃâÒß)Ó븣Êϲ»ÍêÈ«×ô¼Á(ËæºóµÄÃâÒß)È黯È˦Á-Í»´¥ºËµ°°×£¬Ã¿¸ô2ÖܶÔBALB/c´ÆÐÔСÊó½øÐÐÃâÒß(50mg¿¹Ô­/ֻСÊó)¡£³éÈ¡¶¯ÎïѪÇ壬ÀûÓÃELISAÓëWestern blot·½·¨¼ì²âÆäЧ¼ÛÓëÌØÒìÐÔ¡£
[0020]²½Öè3£¬ÓÃ3D5ÔÓ½»Áöϸ°û(¿É¹ºÂòµÃµ½)²úÉúÌØÐÔÐÔ¿¹Ìå¡£3D5ÔÓ½»Áöϸ°û¿ÉÒÔ²úÉúÌØÒìÐÔ¿¹È˦Á-Í»´¥ºËµ°°×¿¹Ìå¡£
[0021]²½Öè4 ;¿¹ÌåÖÆ±¸:3D5ϸ°û´óÁ¿À©Ôö£¬²¢Óɸ¹Ä¤ÄÚ×¢ÉäÈëBALB/cÂãÊóÌåÄÚ£¬²úÉú¸¹Ë®£¬ºóÀûÓÃprotein AÇ׺ͲãÎö´¿»¯,µÃµ½3D5¿¹Ìå¡£
[0022]¼îÐÔÁ×Ëáø:ÔÚELISA²â¶¨ÖУ¬¼îÐÔÁ×ËáøµÄɫԭµ×ÎïÊǶÔÏõ»ù±½Á×ËáÑÎ(p-nitropheny-phosate, ¦Ñ¦­¦±¦±)¡£¦Ñ¦­¦±¦±ÔÚ¼îÐÔÁ×ËáøµÄ×÷ÓÃÏÂÉú³É¶ÔÏõ»ùõª(pNP),ÆäÔÚÈë=405nm´¦ÓÐ×î´óÎüÊÕ¡£
[0023]Ç׺ÍËØ±ê¼ÇµÄ¼îÐÔÁ×Ëáø:½«¼îÐÔÁ×Ëáø½øÐÐÇ׺ÍËØ±ê¼Ç£¬Ç׺ÍËØ¿ÉÓëÉúÎïËØ½áºÏ£¬Æð¼¶Áª·Å´ó×÷Óá£
[0024]ÏÔÉ«¼Á:Ïõ»ù±½Á×Ëáµ¥ÄÆÑΣ¬¿É¼ò³ÆÎª¦Ñ¦­¦±¦±µ¥ÄÆ¡£Óë¦Ñ¦­¦±¦± ¡ªÑù£¬ÓÃÓÚELISAµÄ»¯Ñ§ÏÔÉ«µ×Îï¡£¼îÐÔÁ×ËáøºÍPNPP·´Ó¦ºó£¬ÐγɻÆÉ«Ë®ÈÜ·´Ó¦²úÎ¸Ã²úÎïÔÚ405nm´¦ÓйâÎü¹â¡£
[0025]ELISA ø±ê°å:ÔÚøÁªÃâÒßÎü¸½ÊÔÑé(Enzyme Linked ImmunosorbentAssay, ELISA)ÖУ¬×÷ÎªÔØÌåµÄ¹ÌÏà¾Û±½ÒÒÏ©(Polystyrene)±íÃæ¶Ô¿¹Ô­¡¢¿¹Ìå»ò¿¹Ô­¿¹Ì帴ºÏÎïµÄÎü¸½ÆðÖØÒª×÷Ó᣿¹Ô­¡¢¿¹ÌåºÍÆäËüÉúÎï·Ö×Óͨ¹ý¶àÖÖ»úÖÆÎü¸½ÖÁÔØÌå±íÃæ£¬Õâ°üÀ¨Í¨¹ýÊèË®¼ü¡¢Á÷Ë®/Àë×Ó¼üµÄ±»¶¯Îü¸½£¬Í¨¹ýÒýÈëÆäËü»îÐÔ»ùÍÅÈç°±»ùºÍ̼»ùµÄ¹²¼Û½áºÏ£¬ÒÔ¼°Í¨¹ý±íÃæ¸ÄÐÔºóµÄÇ×Ë®¼ü½áºÏ¡£
[0026]PBS:‘zËỺ³åÒº(phosphate buffer solution),Ũ¶ÈΪ 0.01mol/L¡£
[0027]NaHCO3»º³åÒº:̼ËáÇâÄÆ»º³åÒº£¬Å¨¶ÈΪ200mmol/L£¬PH9.6¡£
[0028]·â±ÕÒº:Ã÷½ºº¬Á¿Îª2.5%µÄPBSTÈÜÒº£¬×÷ÓÃΪ·â±Õ·ÇÌØÒì½áºÏ£¬½µµÍELISA±³
µ©
-5^ O
[0029]PBST:ÔÚ0.01mol/L PBSÖк¬ÓÐ0.05% Tween20¼´ÎªÁ×ËáÑÎÍÂλº³åÒº£¬PBST¡£
[0030]±ê×¼ÇúÏßµÄÖÆ×÷·½·¨ÈçÏÂ:ÿ´ÎÊÔÑéʱ½«Á×Ëữ¦Á -Í»´¥ºËµ°°×ëĶνøÐÐϵÁÐÏ¡ÊÍ£¬ÖÕŨ¶È·Ö±ðΪ0.5,0.25,0.125,0.0625,0.03125¡¢0 ¦Ì mol/L£¬ÓëÑùƷͬʱ½øÐмì²â£¬¶ÁÈ¡Ïà¶ÔÓ¦405nm´¦Îü¹âÖµ£¬×ö³öÆäÓëŨ¶ÈÖ®¼äµÄ¹ØÏµÇúÏß¡£
[0031]ÉúÎïËØ»¯µÄ¿¹È˦Á -Í»´¥ºËµ°°×µ¥¿Ë¡¿¹Ìå3D5£¬ÆäÖÆ±¸·½·¨ÈçÏÂ:
[0032]²½ÖèI£¬ÓÃÎÞË®DMSOÅäÖÆ10mg/mlÉúÎïËØN-ôÇ»ùçúçêõ£Ñǰ·õ¥ÈÜÒº¡£
[0033]²½Öè2£¬ÓÃÅðËáÑλº³åÒº(0.lmol/L, pH8.8)Åä֯ō¶ÈÖÁÉÙΪI~3mg/mlµÄ¿¹Ìå3D5ÈÜÒº£¬Èô¿¹Ìå´¢´æÊ±¼ÓÈëÁ˵þµªÄÆ£¬Ôò±ê¼ÇǰÐëÏÈÔÚÅðËáÑλº³åÒºÖгä·Ö͸ÎöÒÔ³ýÈ¥µþµªÄÆ¡£ [0034]²½Öè3£¬°´25~100 ¦Ì g/mgµÄ±ÈÂʽ«ÉúÎïËØõ¥¼ÓÈ뿹Ìå3D5ÖУ¬»ìºÏ¾ùÔȲ¢ÔÚÊÒÎÂÏ·õÓý4h¡£
[0035]²½Öè4£¬Ã¿250 ¦Ì gÉúÎïËØõ¥ÄÚ¼ÓÈë20 ¦Ì I lmol/LµÄÂÈ»¯ï§£¬ÊÒηõÓýlOmin¡£
[0036]²½Öè5£¬½«¿¹Ìå3D5ÈÜÒºÓÃPBS»òÆäËûËùÐèµÄ»º³åҺ͸Îö£¬ÒÔ³ýȥδ½áºÏµÄÉúÎïËØ¡£
[0037]²½Öè6£¬°´´¿»¯¿¹Ìå3D5µÄ´¢´æ·½·¨±£´æ±ê¼Ç¿¹Ìå3D5¡£
[0038]ÓÅÑ¡µÄ±¾·¢Ã÷µÄ¼ì²â¦Á -Í»´¥ºËµ°°×ÐγÉÄÜÁ¦µÄ·½·¨£¬²½ÖèÈçÏÂ:
[0039]²½Öè1£¬
[0040]È¡¾²ÂöѪ£¬±ØÒªÊ±¿ÉÒÔ¼ÓÈëEDTA¡¢¸ÎËØ»òèÛéÚËΌÄý£¬·ÖÀëѪ½¬²ã±¸Óã»
[0041]²½Öè2£¬
[0042]Ѫ½¬ÖмÓÈëÖØ×éÈ˦Á -Í»´¥ºËµ°°×£¬µÃµ½Á×Ëữ¦Á -Í»´¥ºËµ°°×£»
[0043]²½Öè3£¬
[0044]ELISAø±ê°åÖмÓÈ뿹ÈËÁ×Ëữ-¦Á -Í»´¥ºËµ°°×µ¥¿Ë¡¿¹ÌåºÍÁ×Ëữ¦Á -Í»´¥ºËµ°°×£¬ÒÔ¼°¿¹ÈË_¦Á -Í»´¥ºËµ°°×µ¥¿Ë¡¿¹Ìå½øÐзõÓý£¬¼ÓÈëÇ׺ÍËØ±ê¼ÇµÄ¼îÐÔÁ×Ëáø£¬¶ÔÏõ»ù·ÓÁ×ËáÏÔɫҺ£»
[0045]²½Öè4£¬
[0046]ÔÚ405nm´¦²â¶¨Ã¸±ê°å¸÷¿×µÄÎü¹â¶ÈÖµ£¬¸ù¾Ý±ê×¼ÇúÏß¼ÆËãÁ×Ëữ_ ¦Á -Í»´¥ºËµ°
°×µÄº¬Á¿¡£
[0047]ÌØ±ðÓÅÑ¡µÄ±¾·¢Ã÷µÄ¼ì²â¦Á -Í»´¥ºËµ°°×ÐγÉÄÜÁ¦µÄ·½·¨£¬²½ÖèÈçÏÂ:
[0048]²½Öè1£¬
[0049]Ѫ½¬µÄ·ÖÀë:
[0050]³éÈ¡5-10ml¿¹ÄýѪ(EDTA¡¢¸ÎËØ»òèÛéÚËΌÄý)¡£½«¿¹ÄýѪÉÏϵߵ¹ÇáÇá»ìÔÈ£¬Ìù±Ú¼ÓÈëÖÁ50mlÀëÐĹÜÖУ¬¼Ç¼ȫѪµÄÌå»ý£¬1:1¼ÓÈëPBS£¬³ä·Ö»ìÔÈ¡£
[0051]½«Ï¡ÊͺóµÄȫѪ»ºÂý¼ÓÖÁÁܰÍϸ°û·ÖÀëÒºÉÏ£¬400Xg£¬ÀëÐÄ20min¡£´Ëʱ¹ÜÄÚÒºÌåÓÉÉÏÖÁϵÄ˳ÐòÒÀ´ÎΪѪ½¬²ã¡¢°×Ĥ²ã(ÍâÖÜѪµ¥¸öºËϸ°û)¡¢·ÖÀëÒº²ãÒÔ¼°ºìϸ°û²ã¡£
[0052]ÎüÈ¡±íÃæµÄѪ½¬²ã¡¢·Ö×°£¬_80¡ãC±£´æ±¸Óá£[0053]²½Öè2£¬
[0054]Á×Ëữ¦Á -Í»´¥ºËµ°°×µÄÌåÍâÖÆ±¸:½«Ñª½¬ÓÃPBSÊʵ±Ï¡ÊÍ£¬¼ÓÈëÒ»¶¨Å¨¶ÈµÄÖØ×éÈ˦Á-Í»´¥ºËµ°°×£¬ÔÚºãÎÂÕñµ´Æ÷ÖÐ37¡ãCÕñµ´·õÓýÒ»¶¨Ê±¼ä£¬ÓÚ4¡ãC±£´æ±¸Óá£
[0055]²½Öè3£¬
[0056]°ü±»:ÓÃNaHCO3»º³åҺϡÊÍ¿¹ÈËÁ×Ëữ-¦Á -Í»´¥ºËµ°°×µ¥¿Ë¡¿¹ÌåÖÁÖÕŨ¶ÈΪ
0.1?I ¦Ì g/mL¡£Ïòø±ê°å¸÷¿×¼ÓÈë100 ¦Ì L¸Ã¿¹ÌåÏ¡ÊÍÒº£¬4¡ãC·õÓý¹ýÒ¹¡£ÓÃPBST (ÆäΪº¬ÓÐÍÂεÄPBS)³åϴø±ê°å¸÷¿×£¬¸ù¾ÝÐèҪȷ¶¨³åÏ´´ÎÊýºÍʱ¼ä¡£
[0057]·â±Õ:Ïòø±ê°å¸÷¿×¼ÓÈë100 ¦Ì L·â±ÕÒº(ÆäΪº¬ÓÐÃ÷½ººÍÍÂεÄPBS)£¬ÔÚ37¡ãC·õÓýI?2Сʱ¡£ÓÃPBST³åϴø±ê°å¸÷¿×£¬¸ù¾ÝÐèҪȷ¶¨³åÏ´´ÎÊýºÍʱ¼ä¡£
[0058]Ïò¸÷¿×¼ÓÈë100 ¦Ì LÒÑÖÆ±¸ºÃµÄÁ×Ëữ¦Á -Í»´¥ºËµ°°×ÑùÆ·Ï¡ÊÍÒº£¬ÔÚ37¡ãC·õÓýI?2Сʱ¡£ÓÃPBST³åϴø±ê°å¸÷¿×£¬¸ù¾ÝÐèҪȷ¶¨³åÏ´´ÎÊýºÍʱ¼ä¡£
[0059]Ó÷â±ÕҺϡÊÍÉúÎïËØ»¯µÄ¿¹È˦Á -Í»´¥ºËµ°°×µ¥¿Ë¡¿¹Ìå3D5¿¹ÌåÖÁÖÕŨ¶ÈΪ
0.1?I ¦Ì g/mL¡£Ïòø±ê°åµÄ¸÷¿×¼ÓÈë100 ¦Ì L¸Ã¿¹ÌåÏ¡ÊÍÒº£¬ÔÚ37¡ãC·õÓýI?2Сʱ¡£ÓÃPBST³åϴø±ê°å¸÷¿×£¬¸ù¾ÝÐèҪȷ¶¨³åÏ´´ÎÊýºÍʱ¼ä¡£
[0060]Ó÷â±ÕҺϡÊÍÇ׺ÍËØ±ê¼ÇµÄ¼îÐÔÁ×Ëáø(ÓÉSigma¹«Ë¾³öÊÛ)£¬Ïòø±ê°åµÄ¸÷¿×¼ÓAlOOyL¸ÃøµÄÏ¡ÊÍÒº£¬ÔÚ37¡ãC·õÓý0.5?2Сʱ¡£ÓÃPBST³åϴø±ê°å¸÷¿×£¬¸ù¾ÝÐèҪȷ¶¨³åÏ´´ÎÊýºÍʱ¼ä¡£
[0061]Ïòø±ê°åµÄ¸÷¿×¼ÓÈë100 ¦Ì L ¦Ñ¦­¦±¦± (¶ÔÏõ»ùõªÁ×ËáÏÔɫҺ£¬ÓÉSigma¹«Ë¾³öÊÛ)£¬37¡ãCÏÔÉ«10?50·ÖÖÓ¡£
[0062]²½Öè4£¬
[0063]²â¶¨405nm´¦Ã¸±ê°å¸÷¿×µÄÎü¹â¶ÈÖµ¡£
[0064]¸ù¾ÝÁ×Ëữ¦Á -Í»´¥ºËµ°°×±ê׼ƷŨ¶ÈÓë405nm´¦Îü¹âÖµÖ®¼äµÄ¹ØÏµÇúÏß¼ÆËãÊÜÊÔÕßѪҺÖÐÁ×Ëữ¦Á-Í»´¥ºËµ°°×µÄÐγÉÁ¿¡£
[0065]±¾·¢Ã÷¾­¹ýÑо¿·¢ÏÖ£¬ÉÏÊö·½·¨ÓëÏÖÓм¼ÊõÏà±È¾ßÓÐÈçÏÂÓŵã:
[0066]Õï¶Ï׼ȷÐÔÌá¸ß£»
[0067]Õï¶ÏÁéÃô¶È¼°ÌØÒì¶ÈÌá¸ß¡£
[0068]ÒÔÏÂͨ¹ý±È½ÏÖ¤Ã÷±¾·¢Ã÷µÄÓŵã:
[0069]Foulds PGµÈÈË2011ÄêµÄһƪÎÄÏ×±¨µ¼Ñª½¬ÖÐ×ÔÉíÁ×Ëữ¦Á -Í»´¥ºËµ°°×º¬Á¿¿É×÷ΪÅÁ½ðÉ­²¡Õï¶Ï±ê¼ÇÎ¸Ã·½·¨ROCÇúÏßÏÂÃæ»ýΪ0.68 £»Foulds PGµÈÈË2013ÄêÁíһƪ¹ØÓÚѪ½¬ÖÐ×ÔÉíÁ×Ëữ¦Á-Í»´¥ºËµ°°×º¬Á¿µÄ×ÝÏòÑо¿±¨µ¼£¬¸Ã·½·¨ROCÇúÏßÏÂÃæ»ýΪ
0.717¡£¶ø±¾·¢Ã÷ROCÇúÏßÏÂÃæ»ý¿É´ï0.901£¬Õï¶Ï׼ȷÐÔÃ÷ÏÔ¸ßÓÚǰÕß¡£
[0070]¸ù¾ÝÒÔÉÏÎÄÏ×±¨µ¼ÖеÄROCÇúÏ߿ɵóöÆä´óÖÂÁéÃô¶È¼°ÌØÒì¶È£¬·Ö±ðΪ0.6¼°
0.75¡£¶ø±¾·½·¨ÁéÃô¶È¼°ÌØÒì¶È·Ö±ðΪ0.795¼°0.886£¬¿É¼û±¾·½·¨ÁéÃô¶È¼°ÌØÒì¶È¾ùÓÐÌáÎÅ¡£
[0071]ÓÉÓÚ±¾·¢Ã÷Ч¹ûµÄÓÅÔ½ÐÔ£¬±¾·¢Ã÷È˸ù¾ÝÉÏÊö·½·¨ÖƱ¸ÁËÒ»ÖÖ¼ì²âÊÔ¼ÁºÐ£¬ËùÊöÊÔ¼ÁºÐ°üÀ¨ÒÔÏÂÊÔ¼Á:
[0072]ÖØ×éÈ˦Á-Í»´¥ºËµ°°×
[0073]¿¹ÈËÁ×Ëữ-¦Á -Í»´¥ºËµ°°×µ¥¿Ë¡¿¹Ìå
[0074]ÉúÎïËØ»¯¿¹È˦Á-Í»´¥ºËµ°°×µ¥¿Ë¡¿¹Ìå[0075]¸ù¾ÝÐèÒª£¬ËùÊöÊÔ¼ÁºÐ»¹¿É°üÀ¨ÒÔϸ¨ÖúÊÔ¼Á:
[0076]¼îÐÔÁ×Ëáø£¬»òÇ׺ÍËØ±ê¼ÇµÄ¼îÐÔÁ×Ëáø
[0077]¶ÔÏõ»ù·ÓÁ×ËáÏÔɫҺ
[0078]ELISA ø±ê°å
[0079]PBS
[0080]NaHCO3 »º³åÒº
[0081]·â±ÕÒº
[0082]PBST
[0083]ÆäÖУ¬
[0084]PBSµÄŨ¶ÈΪ0.01mol/L,ÅäÖÆ·½·¨Îª [0085]
Na3HPCK2.72 g
NaH2PCM0.28 g
NaCI9 g
DDWI 000 ml
[0086]NaHCO3»º³åÒºµÄŨ¶ÈΪ200mmol/L£¬pH9.6£¬ÅäÖÆ·½·¨Îª
[0087]NaHCO30.84g
[0088]20% µþµªÄÆ(NaN3) 50 ¦Ì I
[0089]DDff50ml
[0090]·â±ÕÒºµÄŨ¶ÈΪ2.5%£¬ÅäÖÆ·½·¨Îª
[0091]Ã÷½º2.5g
[0092]PBST100mL
[0093]PBST Ϊº¬ 0.05% Tween20 µÄ 0.0ImoI/L PBS£¬ÅäÖÆ·½·¨Îª
[0094]
Na2HPO42.72 g
NaH3PO40.28 g
NaCl9 g
DDW1000 ml
Twccn 20500 ¦ÌL
[0095]ÉÏÊöÊÔ¼ÁºÐµÄʹÓÃÊÇÒÔѪ½¬ÖÐÁ×Ëữ-¦Á-Í»´¥ºËµ°°××÷Ϊ±ê×¼µ°°×£¬ÒÔÁ×Ëữ-¦Á-Í»´¥ºËµ°°×ÓëÎü¹â¶ÈÖµµÄ¹ØÏµÇúÏß×÷Ϊ±ê×¼ÇúÏߣ¬Í¨¹ý²â¶¨Ñù±¾ÖеÄÁ×Ëữ- ¦Á -Í»´¥ºËµ°°×µÄŨ¶ÈÒÔ¼°ÐγÉÂÊ´ïµ½Õï¶ÏÅÁ½ðÉ­²¡µÄÄ¿µÄ¡£
[0096]±¾·¢Ã÷µÄÊÔ¼ÁºÐ£¬¸÷ÊÔ¼Á·Ö±ð°ü×°£¬ÓÅѡʹÓðü×°¹Ü£¬Ã¿¸ö°ü×°¹ÜÖÐ×°ÈëÊÔ¼ÁµÄÁ¿ÒÔ¹»Ò»¸öÑù±¾Ê¹ÓÃÁ¿Îª»ù±¾Á¿£¬¿ÉÒÔÀ©´óµ½10¸ö£¬100¸ö£¬1000¸öÑù±¾µÄʹÓÃÁ¿¡£
[0097]±¾·¢Ã÷µÄÊÔ¼ÁºÐµÄʹÓÃÊǸù¾ÝÉÏÊö¼ì²âѪ½¬ÖÐÁ×Ëữ-¦Á-Í»´¥ºËµ°°×µÄ·½·¨½øÐеģ¬Ê¹ÓÃʱ½«ÊÔ¼ÁºÐÖеÄÊÔ¼Á¸ù¾ÝÐèÒªÅäÖÆ³ÉÏàÓ¦µÄŨ¶È£¬°´ÕÕËùÊö·½·¨²â¶¨¼´¿É¡£
[0098]ΪÑо¿±¾·¢Ã÷£¬»¹½øÐÐÁËÒÔÏÂÖØ¸´ÐÔÊÔÑ飬¾«ÃܶÈÊÔÑ飬¼ì²â·½·¨µÄɸѡµÈÊÔÑé[0099] ÏàͬÑù±¾Öظ´ÊµÑé3´Î£¬½á¹ûÏÔʾÏà¶Ô±ê×¼²îRSDΪ0.60%¡£
[0100]½«ÊµÊ©Àý3ÖÐÖÆ±¸µÄÊÔ¼ÁºÐ·Ö±ðÈ¡ÈýÅú½øÐо«ÃܶÈʵÑé¡£ÒÔʵʩÀý3ÖÐËù³éÈ¡µÄÊÔ¼ÁºÐ²â¶¨Èý·Ý¸ß¡¢ÖС¢µÍÖµÑù±¾0.5ymol/L¡¢0.125 ¦Ì mol/LºÍ0.03125 ¦Ì mol/L¸÷8´Î¡£¼ÆËã²â¶¨Å¨¶ÈµÄ±äÒìϵÊý¡£ÊµÊ©Àý3ÖеÄÈýÅúÊÔ¼ÁºÐµÄ½á¹û±íÃ÷±äÒìϵÊýСÓÚ8.0%¡£
[0101]²ÉÓÃÆåÅ̵ζ¨ÊÔÑéÈ·¶¨¿¹Ìå°ü±»Å¨¶ÈÒÔ¼°ÉúÎïËØ»¯¿¹ÌåŨ¶È¡£¸ù¾Ý³õ²½È·¶¨µÄŨ¶ÈËõС¼ä¾à£¬ÔÙ×ö½øÒ»²½ÆåÅ̵樣¬È·¶¨×î¼ÑÊÔÑéÌõ¼þ¡£×îÖÕÈ·¶¨°ü±»Å¨¶ÈΪ0.1~I ¦Ì g/mL,ÉúÎïËØ»¯¿¹ÌåŨ¶ÈΪ0.1~I ¦Ì g/mL¡£
¡¾×¨Àû¸½Í¼¡¿

¡¾¸½Í¼ËµÃ÷¡¿:
[0102]ͼ1Ϊºìϸ°û·ÖÀë¹ý³ÌÖУ¬²»Í¬³É·Ö·Ö²ãʾÒâͼ¡£
[0103]ͼ2Ϊ92Àý¶ÔÕÕÓëH)»¼ÕßѪ½¬ÖÐÁ×Ëữa -SynÐγÉÁ¿µÄELISA¼ì²â½á¹û¡£¡¾¾ßÌåʵʩ·½Ê½¡¿:
[0104]ÒÔÏÂͨ¹ýʵʩÀý½øÒ»²½ËµÃ÷±¾·¢Ã÷¡£
[0105]ʵʩÀý1£¬
[0106]¾ßÌå²½ÖèÈçÏÂ:
[0107](1)Ѫ½¬µÄ·ÖÀë:
[0108].³éÈ¡5-10ml¿¹ÄýѪ(EDTA¡¢¸ÎËØ»òèÛéÚËΌÄý)¡£½«¿¹ÄýѪÉÏϵߵ¹ÇáÇá»ìÔÈ£¬Ìù±Ú¼ÓÈëÖÁ50mlÀëÐĹÜÖУ¬¼Ç¼ȫѪµÄÌå»ý£¬1:1¼ÓÈëPBS£¬³ä·Ö»ìÔÈ¡£
[0109]?½«Ï¡ÊͺóµÄȫѪ»ºÂý¼ÓÖÁÁܰÍϸ°û·ÖÀëÒºÉÏ£¬400Xg£¬ÀëÐÄ20min¡£´Ëʱ¹ÜÄÚÒºÌåÓÉÉÏÖÁϵÄ˳ÐòÒÀ´ÎΪѪ½¬²ã¡¢°×Ĥ²ã(ÍâÖÜѪµ¥¸öºËϸ°û)¡¢·ÖÀëÒº²ãÒÔ¼°ºìϸ°û²ã¡£
[0110].ÎüÈ¡±íÃæµÄѪ½¬²ã¡¢·Ö×°£¬-80¡ãC±£´æ±¸Óá£
[0111](2)Á×Ëữ¦Á -Í»´¥ºËµ°°×µÄÌåÍâÖÆ±¸:½«Ñª½¬ÓÃPBSÊʵ±Ï¡ÊÍ£¬¼ÓÈëÒ»¶¨Å¨¶ÈµÄÖØ×éÈ˦Á-Í»´¥ºËµ°°×£¬ÔÚºãÎÂÕñµ´Æ÷ÖÐ37¡ãCÕñµ´·õÓýÒ»¶¨Ê±¼ä£¬ÓÚ4¡ãC±£´æ±¸Óá£
[0112](3)°ü±»:ÓÃNaHCOj^³åҺϡÊÍ¿¹ÈËÁ×Ëữ-¦Á -Í»´¥ºËµ°°×µ¥¿Ë¡¿¹ÌåÖÁÖÕŨ¶ÈΪ0.1~I ¦Ì g/mL¡£Ïòø±ê°å¸÷¿×¼ÓÈë100 ¦Ì L¸Ã¿¹ÌåÏ¡ÊÍÒº£¬4¡ãC·õÓý¹ýÒ¹¡£ÓÃPBST (ÆäΪº¬ÓÐÍÂεÄPBS)³åϴø±ê°å¸÷¿×£¬¸ù¾ÝÐèҪȷ¶¨³åÏ´´ÎÊýºÍʱ¼ä¡£
[0113](4)·â±Õ:Ïòø±ê°å¸÷¿×¼ÓÈë100 ¦Ì L·â±ÕÒº(ÆäΪº¬ÓÐÃ÷½ººÍÍÂεÄPBS)£¬ÔÚ37¡ãC·õÓýI~2Сʱ¡£ÓÃPBST³åϴø±ê°å¸÷¿×£¬¸ù¾ÝÐèҪȷ¶¨³åÏ´´ÎÊýºÍʱ¼ä¡£
[0114](5)Ïò¸÷¿×¼ÓÈë100 ¦Ì LÒÑÖÆ±¸ºÃµÄÁ×Ëữ¦Á -Í»´¥ºËµ°°×ÑùÆ·Ï¡ÊÍÒº£¬ÔÚ37 V·õÓýI~2Сʱ¡£ÓÃPBST³åϴø±ê°å¸÷¿×£¬¸ù¾ÝÐèҪȷ¶¨³åÏ´´ÎÊýºÍʱ¼ä¡£
[0115](6)Ó÷â±ÕҺϡÊÍÉúÎïËØ»¯µÄ¿¹È˦Á -Í»´¥ºËµ°°×µ¥¿Ë¡¿¹Ìå3D5¿¹ÌåÖÁÖÕŨ¶ÈΪ0.1~I ¦Ì g/mL¡£Ïòø±ê°åµÄ¸÷¿×¼ÓÈë100 ¦Ì L¸Ã¿¹ÌåÏ¡ÊÍÒº£¬ÔÚ37¡ãC·õÓýI~2Сʱ¡£ÓÃPBST³åϴø±ê°å¸÷¿×£¬¸ù¾ÝÐèҪȷ¶¨³åÏ´´ÎÊýºÍʱ¼ä¡£
[0116](7)Ó÷â±ÕҺϡÊÍÇ׺ÍËØ±ê¼ÇµÄ¼îÐÔÁ×Ëáø(ÓÉSigma¹«Ë¾³öÊÛ)£¬Ïòø±ê°åµÄ¸÷¿×¼ÓÈë100 ¦Ì L¸ÃøµÄÏ¡ÊÍÒº£¬ÔÚ37¡ãC·õÓý0.5~2Сʱ¡£ÓÃPBST³åϴø±ê°å¸÷¿×£¬¸ù¾ÝÐèҪȷ¶¨³åÏ´´ÎÊýºÍʱ¼ä¡£
[0117](8)Ïòø±ê°åµÄ¸÷¿×¼ÓÈë100 ¦Ì LpNPP(¶ÔÏõ»ù·ÓÁ×ËáÏÔɫҺ£¬ÓÉSigma¹«Ë¾³öÊÛ)£¬37¡ãCÏÔÉ«10~50·ÖÖÓ¡£[0118](9)²â¶¨405nm´¦Ã¸±ê°å¸÷¿×µÄÎü¹â¶ÈÖµ¡£
[0119](10)¸ù¾ÝÁ×Ëữ¦Á -Í»´¥ºËµ°°×±ê׼ƷŨ¶ÈÓë405nm´¦Îü¹âÖµÖ®¼äµÄ¹ØÏµÇúÏß¼ÆËãÊÜÊÔÕßѪҺÖÐÁ×Ëữ¦Á-Í»´¥ºËµ°°×µÄÐγÉÁ¿¡£
[0120]ʵʩÀý2£¬
[0121 ] Ѫ½¬´Ù½ø¦Á -Í»´¥ºËµ°°×Á×ËữÐÞÊεÄÄÜÁ¦µÄ¼ì²â
[0122]²ÉÓÃÏà¶Ô¶¨Á¿ELISA·¨£¬¶Ô44ÀýÁÙ´²Õï¶ÏµÄÅÁ½ðÉ­²¡È˺Í44Àý½¡¿µ¶ÔÕÕѪ½¬´Ù½ø¦Á-Í»´¥ºËµ°°×Á×ËữÐÞÊεÄÄÜÁ¦½øÐÐÁ˼ì²â¡£½á¹ûÏÔʾÅÁ½ðÉ­²¡ÈËѪ½¬ÖÐÁ×Ëữ¦Á -Í»´¥ºËµ°°×ÐγÉÁ¿Îª68.2 ¦Ì mol/L ;¶øÕý³£½¡¿µ¶ÔÕÕѪ½¬ÖÐÁ×Ëữ¦Á -Í»´¥ºËµ°°×ÐγÉÁ¿Îª41.6 ¦Ì mol/L¡£ÅÁÉ­²¡ÈËѪ½¬ÖÐÁ×Ëữ¦Á -Í»´¥ºËµ°°×ÐγÉÁ¿Ã÷ÏÔ¸ßÓÚÕý³£½¡¿µ¶ÔÕÕ(P < 0.01)¡£
[0123]ʵʩÀý3£¬
[0124]ÊÔ¼ÁºÐ³É·Ö¾ÙÀý
[0125]ÖØ×éÈ˦Á -Í»´¥ºËµ°°×£¬IOmg
[0126]¿¹ÈËÁ×Ëữ-¦Á-Í»´¥ºËµ°°×µ¥¿Ë¡¿¹ÌåIOyg
[0127]ÉúÎïËØ»¯µÄ¿¹È˦Á -Í»´¥ºËµ°°×µ¥¿Ë¡¿¹Ìå10 ¦Ì g
[0128]¼îÐÔÁ×Ëáø£¬»òÇ׺ÍËØ±ê¼ÇµÄ¼îÐÔÁ×Ëáø5 ¦Ì I
[0129]¶ÔÏõ»ù·ÓÁ×ËáÏÔɫҺIOml
[0130]ELISA ø±ê°å
[0131]PBSlOml
[0132]NaHCO3 »º³åÒº IOml
[0133]·â±ÕÒº20ml
[0134]PBST500ml
[0135]ÒÔÏÂΪ²Î¿¼Îļþ:
[0136]Reference List
[0137](I) Lotharius J, Brundin P.Pathogenesis of Parkinson' sdisease: dopamine, vesicles and alpha-synuclein.Nat Rev Neurosci2002Dec £»3:932-942.[0138](2) Siderowf A, Stern M.Update on Parkinson disease.Ann InternMed2003Aprl5 £» 138:651-658.[0139](3) Spillantini MG, Schmidt ML, Lee VM, Trojanowski JQ, Jakes R, GoedertM.Alpha-synuclein in Lewy bodies.Naturel997Aug28 £»388:839-840.[0140](4) Sato H, Kato T, Arawaka S.The role of Ser 129phosphorylation ofalpha-synuclein in neurodegeneration of Parkinson's disease:a review of in vivomodels.Rev Neurosci2013 £»24:115-123.[0141](5) Braithwaite SP, Stock JB, Mouradian MM.alpha-Synuc I e inphosphorylation as a therapeutic target in Parkinson' s disease.RevNeurosci2012 £»23:191-198.[0142](6) Fu j iwara H, Hasegawa M, Dohmae N, et al.alpha-Synuclein isphosphorylated in synucleinopathy lesions.Nat Cell Biol2002Feb ;4:160-164.[0143](7)Foulds PG£¬Mitchell JDj Parker A£¬et al.Phosphorylated alpha-synucleincan be detected in blood plasma and is potentially a useful biomarker forParkinson¡¯s disease.FASEB J2011Dec £»25:4127-4137.[0144](8)Hasegawa Mj Fujiwara H£¬Nonaka T£¬et al.Phosphorylated alpha-synucleinis ubiquitinated in alpha-synucleinopathy lesions.J Biol Chem2002Decl3 £»277:49071-49076.[0145](9)Cavallarin Nj Vicario M£¬Negro A.The role of phosphorylation insynucleinopathies: focus on Parkinson¡¯s disease.CNS Neurol Disord DrugTargets2010Aug ;9:471_481.[0146](10)Foulds P£¬Mann DM, Allsop D.Phosphorylated alpha-synuclein as apotential biomarker for Parkinson¡¯s disease and related disorders.Expert RevMol Diagn2012Mar ;12:115-117¡£
¡¾È¨ÀûÒªÇó¡¿
1.Ò»ÖÖÓÃÓÚ¼ì²âÁ×ËữÐÞÊεĦÁ-Í»´¥ºËµ°°×º¬Á¿µÄÊÔ¼ÁºÐ£¬ÊÔ¼ÁºÐÖаüÀ¨ÒÔÏÂÊÔ¼Á:ÖØ×éÈ˦Á -Í»´¥ºËµ°°×£¬¿¹ÈËÁ×Ëữ-¦Á -Í»´¥ºËµ°°×µ¥¿Ë¡¿¹Ì壬¿¹È˦Á-Í»´¥ºËµ°°×µ¥¿Ë¡¿¹Ìå»òÉúÎïËØ»¯µÄ¿¹È˦Á-Í»´¥ºËµ°°×µ¥¿Ë¡¿¹Ìå¡£
2.¸ù¾ÝȨÀûÒªÇó1ËùÊöµÄÊÔ¼ÁºÐ£¬¸ù¾ÝÐèÒª£¬ËùÊöÊÔ¼ÁºÐ»¹¿É°üÀ¨ÒÔϸ¨ÖúÊÔ¼Á: ¼îÐÔÁ×Ëáø£¬»òÇ׺ÍËØ±ê¼ÇµÄ¼îÐÔÁ×Ëáø ¶ÔÏõ»ù·ÓÁ×ËáÏÔɫҺ ELISAø±ê°å PBS NaHCO3»º³åÒº ·â±ÕÒº PBST¡£
3.¸ù¾ÝȨÀûÒªÇó2ËùÊöµÄÊÔ¼ÁºÐ£¬ÆäÖÐ PBS µÄŨ¶ÈΪ 0.01mol/L, NaHCO3 »º³åÒºµÄŨ¶ÈΪ 200mmol/L£¬pH9.6£¬ ·â±ÕÒºµÄŨ¶ÈΪ2.5%£¬
PBST Ϊº¬ 0.05% Tween-20 µÄ 0.01M PBS¡£
4.¸ù¾ÝȨÀûÒªÇó2ËùÊöµÄÊÔ¼ÁºÐ£¬ÆäÖи÷ÊÔ¼Á·Ö±ð°ü×°£¬Ã¿¸ö°ü×°×°ÈëÊÔ¼ÁµÄÁ¿ÒÔ¹»Ò»¸öÑù±¾Ê¹ÓÃÁ¿Îª»ù±¾Á¿£¬¿ÉÒÔÀ©´óµ½10¸ö£¬100¸ö£¬1000¸öÑù±¾µÄʹÓÃÁ¿¡£
5.¸ù¾ÝȨÀûÒªÇó1ËùÊöµÄÊÔ¼ÁºÐ£¬ÆäÖп¹ÈËÁ×Ëữ¦Á-Í»´¥ºËµ°°×µ¥¿Ë¡¿¹ÌåΪ4E6¿¹Ìå¡£
6.¸ù¾ÝȨÀûÒªÇó1ËùÊöµÄÊÔ¼ÁºÐ£¬ËùÊö¿¹È˦Á-Í»´¥ºËµ°°×µ¥¿Ë¡¿¹ÌåΪ3D5¿¹Ìå¡£
7.ÉúÎïËØ»¯µÄ¿¹È˦Á-Í»´¥ºËµ°°×µ¥¿Ë¡¿¹Ìå3D5£¬ÆäÖÆ±¸·½·¨ÈçÏÂ: ²½Öè1£¬ÓÃÎÞË®DMSOÅäÖÆ10mg/mlÉúÎïËØN-ôÇ»ùçúçêõ£Ñǰ·õ¥ÈÜÒº¡£ ²½Öè2£¬ÓÃ0.lmol/L, pH8.8ÅðËáÑλº³åÒºÅä֯ō¶ÈΪI~3mg/mlµÄ¿¹Ìå3D5ÈÜÒº£¬Èô¿¹Ìå´¢´æÊ±¼ÓÈëÁ˵þµªÄÆ£¬Ôò±ê¼ÇǰÐëÏÈÔÚÅðËáÑλº³åÒºÖгä·Ö͸ÎöÒÔ³ýÈ¥µþµªÄÆ¡£ ²½Öè3£¬°´25~100 ¦Ì g/mgµÄ±ÈÂʽ«ÉúÎïËØõ¥¼ÓÈ뿹Ìå3D5ÖУ¬»ìºÏ¾ùÔȲ¢ÔÚÊÒÎÂÏ·õÓý4h¡£ ²½Öè4£¬Ã¿250 ¦Ì gÉúÎïËØõ¥ÄÚ¼ÓÈë20 ¦Ì I lmol/LµÄÂÈ»¯ï§£¬ÊÒηõÓýlOmin¡£ ²½Öè5£¬½«¿¹Ìå3D5ÈÜÒºÓÃPBS»òÆäËûËùÐèµÄ»º³åҺ͸Îö£¬ÒÔ³ýȥδ½áºÏµÄÉúÎïËØ¡£ ²½Öè6£¬°´´¿»¯¿¹Ìå3D5µÄ´¢´æ·½·¨±£´æ±ê¼Ç¿¹Ìå3D5¡£
8.Ò»ÖÖÓÃȨÀûÒªÇó1µÄÊÔ¼ÁºÐ¼ì²âÁ×Ëữ¦Á-Í»´¥ºËµ°°×º¬Á¿µÄ·½·¨£¬°üÀ¨ÒÔϲ½Öè: (1)·ÖÀëѪ½¬£» (2)¼ÓÈëÖØ×éÈ˦Á-Í»´¥ºËµ°°×£¬µÃµ½Á×Ëữ¦Á-Í»´¥ºËµ°°×£» (3)¿¹ÈËÁ×Ëữ-¦Á -Í»´¥ºËµ°°×µ¥¿Ë¡¿¹ÌåºÍÁ×Ëữ¦Á -Í»´¥ºËµ°°×ÒÔ¼°¿¹È˦Á -Í»´¥ºËµ°°×µ¥¿Ë¡¿¹Ìå·õÓý£¬Ëæºó¼ÓÈë¼îÐÔÁ×ËáøºÍÏÔÉ«¼Á£¬½øÐÐÏÔÉ«£» (4)Ó÷ֹâ¹â¶È·¨¶ÔÏÔÉ«µÄÑùÆ·½øÐÐÎü¹â¶È²â¶¨£¬¸ù¾Ý±ê×¼ÇúÏß¼ÆËãÑùÆ·ÖÐÁ×Ëữ¦Á-Í»´¥ºËµ°°×µÄº¬Á¿¡£
9.¸ù¾ÝȨÀûÒªÇó8ËùÊöµÄ·½·¨£¬²½ÖèÈçÏÂ:²½Öè1£¬ È¡¾²ÂöѪ£¬±ØÒªÊ±¿ÉÒÔ¼ÓÈëEDTA¡¢¸ÎËØ»òèÛéÚËΌÄý£¬·ÖÀëѪ½¬²ã±¸Óã» ²½Öè2£¬ Ѫ½¬ÖмÓÈëÖØ×éÈ˦Á -Í»´¥ºËµ°°×£¬µÃµ½Á×Ëữ¦Á -Í»´¥ºËµ°°×£» ²½Öè3£¬ ELISAø±ê°åÖмÓÈ뿹ÈËÁ×Ëữ- ¦Á -Í»´¥ºËµ°°×µ¥¿Ë¡¿¹ÌåºÍÁ×Ëữ¦Á -Í»´¥ºËµ°°×£¬ÒÔ¼°¿¹ÈË_¦Á -Í»´¥ºËµ°°×µ¥¿Ë¡¿¹Ìå½øÐзõÓý£¬¼ÓÈëÇ׺ÍËØ±ê¼ÇµÄ¼îÐÔÁ×Ëáø£¬¶ÔÏõ»ù·ÓÁ×ËáÏÔɫҺ£» ²½Öè4£¬ ÔÚ405nm´¦²â¶¨Ã¸±ê°å¸÷¿×µÄÎü¹â¶ÈÖµ£¬¸ù¾Ý±ê×¼ÇúÏß¼ÆËãÁ×Ëữ_ ¦Á _Í»´¥ºËµ°°×µÄº¬Á¿¡£
10.¸ù¾ÝȨÀûÒªÇó9ËùÊöµÄ·½·¨£¬²½ÖèÈçÏÂ: ²½Öè1£¬ Ѫ½¬µÄ·ÖÀë: ³éÈ¡5-10ml¿¹ÄýѪ(EDTA¡¢¸ÎËØ»òèÛéÚËΌÄý)¡£½«¿¹ÄýѪÉÏϵߵ¹ÇáÇá»ìÔÈ£¬Ìù±Ú¼ÓÈëÖÁ50mlÀëÐĹÜÖУ¬¼Ç¼ȫѪµÄÌå»ý£¬1:1¼ÓÈëPBS,³ä·Ö»ìÔÈ¡£ ½«Ï¡ÊͺóµÄȫѪ»ºÂý¼ÓÖÁÁܰÍϸ°û·ÖÀëÒºÉÏ£¬400Xg£¬ÀëÐÄ20min¡£´Ëʱ¹ÜÄÚÒºÌåÓÉÉÏÖÁϵÄ˳ÐòÒÀ´ÎΪѪ½¬²ã¡¢°×Ĥ²ã(ÍâÖÜѪµ¥¸öºËϸ°û)¡¢·ÖÀëÒº²ãÒÔ¼°ºìϸ°û²ã¡£ ÎüÈ¡±íÃæµÄѪ½¬²ã¡¢·Ö×°£¬_80¡ãC±£´æ±¸Óᣠ²½Öè2£¬ Á×Ëữ¦Á-Í»´¥ºËµ°°×µÄÌåÍâÖÆ±¸:½«Ñª½¬ÓÃPBSÊʵ±Ï¡ÊÍ£¬¼ÓÈëÒ»¶¨Å¨¶ÈµÄÖØ×éÈ˦Á-Í»´¥ºËµ°°×£¬ÔÚºãÎÂÕñµ´Æ÷ÖÐ37¡ãCÕñµ´·õÓýÒ»¶¨Ê±¼ä£¬ÓÚ4¡ãC±£´æ±¸Óᣠ²½Öè3£¬ °ü±»:ÓÃNaHCOj^³åҺϡÊÍ¿¹ÈËÁ×Ëữ-¦Á -Í»´¥ºËµ°°×µ¥¿Ë¡¿¹ÌåÖÁÖÕŨ¶ÈΪ0.1~I ¦Ì g/mL¡£Ïòø±ê°å¸÷¿×¼ÓÈë100 ¦Ì L¸Ã¿¹ÌåÏ¡ÊÍÒº£¬4¡ãC·õÓý¹ýÒ¹¡£ÓÃPBST (ÆäΪº¬ÓÐÍÂεÄPBS)³åϴø±ê°å¸÷¿×£¬¸ù¾ÝÐèҪȷ¶¨³åÏ´´ÎÊýºÍʱ¼ä¡£ ·â±Õ:Ïòø±ê°å¸÷¿×¼ÓÈë100 ¦Ì L·â±ÕÒº(ÆäΪº¬ÓÐÃ÷½ººÍÍÂεÄPBS)£¬ÔÚ37¡ãC·õÓýI~2Сʱ¡£ÓÃPBST³åϴø±ê°å¸÷¿×£¬¸ù¾ÝÐèҪȷ¶¨³åÏ´´ÎÊýºÍʱ¼ä¡£ Ïò¸÷¿×¼ÓÈë100 ¦Ì LÒÑÖÆ±¸ºÃµÄÁ×Ëữ¦Á -Í»´¥ºËµ°°×ÑùÆ·Ï¡ÊÍÒº£¬ÔÚ37¡ãC·õÓýI~2Сʱ¡£ÓÃPBST³åϴø±ê°å¸÷¿×£¬¸ù¾ÝÐèҪȷ¶¨³åÏ´´ÎÊýºÍʱ¼ä¡£ Ó÷â±ÕҺϡÊÍÉúÎïËØ»¯µÄ¿¹È˦Á -Í»´¥ºËµ°°×µ¥¿Ë¡¿¹Ìå3D5¿¹ÌåÖÁÖÕŨ¶ÈΪ0.1~I ¦Ì g/mL¡£Ïòø±ê°åµÄ¸÷¿×¼ÓÈë100 ¦Ì L¸Ã¿¹ÌåÏ¡ÊÍÒº£¬ÔÚ37¡ãC·õÓýI~2Сʱ¡£ÓÃPBST³åϴø±ê°å¸÷¿×£¬¸ù¾ÝÐèҪȷ¶¨³åÏ´´ÎÊýºÍʱ¼ä¡£ Ó÷â±ÕҺϡÊÍÇ׺ÍËØ±ê¼ÇµÄ¼îÐÔÁ×Ëáø£¬Ïòø±ê°åµÄ¸÷¿×¼ÓÈë100 ¦Ì L¸ÃøµÄÏ¡ÊÍÒº£¬ÔÚ37¡ãC·õÓý0.5~2Сʱ¡£ÓÃPBST³åϴø±ê°å¸÷¿×£¬¸ù¾ÝÐèҪȷ¶¨³åÏ´´ÎÊýºÍʱ¼ä¡£ Ïòø±ê°åµÄ¸÷¿×¼ÓÈë100 ¦Ì L ¦Ñ¦­¦±¦± (¶ÔÏõ»ù·ÓÁ×ËáÏÔɫҺ)£¬37¡ãCÏÔÉ«10~50·ÖÖÓ¡£ ²½Öè4£¬ ²â¶¨405nm´¦Ã¸±ê°å¸÷¿×µÄÎü¹â¶ÈÖµ¡£ ¸ù¾ÝÁ×Ëữ¦Á -Í»´¥ºËµ°°×±ê׼ƷŨ¶ÈÓë405nm´¦Îü¹âÖµÖ®¼äµÄ¹ØÏµÇúÏß¼ÆËãÊÜÊÔÕßѪҺÖÐÁ× Ëữ¦Á-Í»´¥ºËµ°°×µÄÐγÉÁ¿¡£
¡¾Îĵµ±àºÅ¡¿G01N33/577GK103954763SQ201410193762
¡¾¹«¿ªÈÕ¡¿2014Äê7ÔÂ30ÈÕ ÉêÇëÈÕÆÚ:2014Äê5ÔÂ8ÈÕ ÓÅÏÈȨÈÕ:2014Äê5ÔÂ8ÈÕ
¡¾·¢Ã÷Õß¡¿ÓÚ˳, ÒüÄÈ, ÑîΡΡ, Àîê¿ ÉêÇëÈË:Ê×¶¼Ò½¿Æ´óѧÐûÎäÒ½Ôº

  • רÀûÃû³Æ£º³¬Ç¿ÄÍÄ¥ÈȵçżÈȵç×軤Ì×µÄÖÆ×÷·½·¨¼¼ÊõÁìÓò£º±¾ÊµÓÃÐÂÐÍÉæ¼°»¤Ì×£¬ÓÈÆäÊÇÉæ¼°Ò»ÖÖÓÃÓÚ²âÁ¿Î¶ȵij¬Ç¿ÄÍÄ¥ÈȵçżÈȵç×軤Ìס£±³¾°¼¼Êõ£ºÍ¨³£ÔÚʹÓÃÈȵçżÈȵç×è²âÁ¿·Û³¾½éÖʵÄζÈʱ£¬½«ÄÚ×°ÓÐÈÈÃô´«¸ÐÆ÷µÄÌ×¹ÜÉìÈë·Û³¾½éÖÊÖвâÁ¿Î¶ȣ¬ÓÉÓÚ·Û³¾ÔÚ
  • רÀûÃû³Æ£º¶à¹¦ÄÜѹÁ¦±í½ÓÍ·µÄÖÆ×÷·½·¨¼¼ÊõÁìÓò£º±¾ÊµÓÃÐÂÐÍÉæ¼°ÒºÑ¹»úе¼¼ÊõÁìÓò£¬ÌرðÉæ¼°ÔÚ²ðжѹÁ¦±í¹ý³ÌÖÐÄÜ´ïµ½¿ìËÙ¡¢ °²È«·Åѹ£¬²¢ÇÒÔÚ°²×°¹ý³ÌÖпÉÒÔÈÎÒâµ÷ÕûѹÁ¦±í·½ÏòµÄ½ÓÍ·£¬ÊÇ©`Öֶ๦ÄÜѹ¥«±í½ÓÍ·¡£±³¾°¼¼Êõ£ºÓÍÆøÌïÉú²úÉ豸ÖУ¬Ò»Ð©¥¨ÒÕÉ豸¼°
  • רÀûÃû³Æ£ºÒ»ÖÖ±äѹÆ÷Ìúо½ÓµØ½»Ö±Á÷ÔÚÏß¼à²â×°ÖõÄÖÆ×÷·½·¨¼¼ÊõÁìÓò£º±¾ÊµÓÃÐÂÐÍÉæ¼°Ò»ÖÖ¸ßѹ±äѹÆ÷ÔÚÏß¼à²âÉ豸£¬ÊÇÒ»ÖÖ±äѹÆ÷Ìúо½ÓµØ½»Ö±Á÷ÔÚ Ïß¼à²â×°Öᣱ³¾°¼¼Êõ£º±äѹÆ÷µÄÈÆ×éºÍÌúоÊÇ´«µÝ¡¢±ä»»µç´ÅÄÜÁ¿µÄÖ÷Òª²¿¼þ¡£±£Ö¤ËüÃǵݲȫÊDZäѹ Æ÷¿É¿¿ÔË
  • רÀûÃû³Æ£ºÒ»ÖÖÓÃÓÚ²âÊÔ¹âÏËÍ¿²ã°þÀëÁ¦µÄ×°ÖõÄÖÆ×÷·½·¨¼¼ÊõÁìÓò£º±¾ÊµÓÃÐÂÐÍÉæ¼°Ò»ÖÖÓÃÓÚ²âÊÔ¹âÏËÍ¿²ã°þÀëÁ¦µÄ×°Öᣠ±³¾°¼¼Êõ£º¹âÏËͨÐż¼Êõ´Ó¹âͨÐÅÖÐÍÑÓ±¶ø³ö£¬ÒѳÉΪÏÖ´úͨÐŵÄÖ÷ÒªÖ§ÖùÖ®Ò»£¬ÔÚÏÖ´úµç ÐÅÍøÖÐÆðמÙ×ãÇáÖØµÄ×÷Óá£Èçͼ3ËùʾµÄ¹âÏË1£¬
  • רÀûÃû³Æ£º»ùÓÚ½üºìÍâ¹âÆ×ÓëÐÅÏ¢´¦ÀíµÄÓñÃׯ·ÖÖ¼ø±ð·½·¨¼¼ÊõÁìÓò£º±¾·¢Ã÷Éæ¼°ÓñÃׯ·Öֵļø±ð¼¼ÊõÁìÓò£¬ÌرðÊÇÒ»ÖÖ»ùÓÚ½üºìÍâ¹âÆ×ÓëÐÅÏ¢´¦ÀíµÄÓñÃׯ·ÖÖ¼ø±ð·½·¨¡£ ±³¾°¼¼Êõ£ºÏÖÓеÄÅ©×÷ÎïÆ·ÖÖ¼ø±ð·½·¨ÓÐÐÎ̬ѧ·½·¨¡¢Ó«¹âɨÃè¼ø¶¨·¨¡¢»¯Ñ§¼ø¶¨·¨ºÍµçÓ¾¼ø¶¨·¨µÈ
  • רÀûÃû³Æ£ºÒ»ÖÖÍß˹¼ÌµçÆ÷У׼¼ì²â×°Öü°·½·¨Ò»ÖÖÍß˹¼ÌµçÆ÷У׼¼ì²â×°Öü°·½·¨¼¼ÊõÁìÓò£º±¾·¢Ã÷Éæ¼°µçÁ¦ÏµÍ³µÄ±äѹÆ÷°²È«±£»¤¼¼ÊõÁìÓò£¬ÓÈÆäÊÇÉæ¼°Ò»ÖÖÍß˹¼ÌµçÆ÷У׼¼ì²â×°Öü°·½·¨¡£±³¾°¼¼Êõ£ºÔÚµçÁ¦ÏµÍ³ºÍ¹©ÓõçϵͳÖУ¬±äѹÆ÷ÊÇÒ»ÖÖ¼°ÆäÖØÒªµÄµçÁ¦É豸£¬
ɽ¶«ÑÇÐÇÓÎÏ·¹ÙÍø»ú´²ÓÐÏÞ¹«Ë¾
È«¹ú·þÎñÈÈÏߣº13062023238
µç»°£º13062023238
µØÖ·£ºëøÖÝÊÐÁúȪ¹¤ÒµÔ°68ºÅ
¹Ø¼ü´Ê£ºÏ³´²£¬Êý¿ØÏ³´²£¬ÁúÃÅϳ´²
¹«Ë¾¶þάÂë
Copyright 2010-2024 °æÈ¨ËùÓÐ All rights reserved ³ICP±¸19044495ºÅ-12
¡¾ÍøÕ¾µØÍ¼¡¿¡¾sitemap¡¿